{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:48:44Z","timestamp":1789469324977,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.molimm.2017.03.018","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T15:05:20Z","timestamp":1492527920000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus"],"prefix":"10.1016","volume":"87","author":[{"given":"Mingfang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Datang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.molimm.2017.03.018_bib0005","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.39504","article-title":"Genome-wide association study in an amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of european admixture","volume":"68","author":"Alarcon-Riquelme","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.molimm.2017.03.018_bib0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0961203311426569","article-title":"Current state of evidence on \u2018off-label' therapeutic options for systemic lupuserythematosus, including biological immunosuppressive agents, in Germany, Austriaand Switzerland-a consensus report","volume":"21","author":"Aringer","year":"2012","journal-title":"Lupus"},{"issue":"5252","key":"10.1016\/j.molimm.2017.03.018_bib0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.271.5252.1128","article-title":"IRAK: a kinase associated with the interleukin-1 receptor","volume":"271","author":"Cao","year":"1996","journal-title":"Science (80-)"},{"issue":"11","key":"10.1016\/j.molimm.2017.03.018_bib0020","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/rheumatology\/keq214","article-title":"Occupational and environmental exposures and risk of systemic lupuserythematosus: silica, sunlight, solvents","volume":"49","author":"Cooper","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.molimm.2017.03.018_bib0025","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: critical regulators of innateimmune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.molimm.2017.03.018_bib0030","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine newsusceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.molimm.2017.03.018_bib0035","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for theclassification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.molimm.2017.03.018_bib0040","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1002\/art.23060","article-title":"Identification of novel susceptibility genes in childhood-onset systemic lupuserythematosus using a uniquely designed candidate gene pathway platform","volume":"56","author":"Jacob","year":"2007","journal-title":"Arthritis Rheumatol."},{"issue":"15","key":"10.1016\/j.molimm.2017.03.018_bib0045","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1073\/pnas.0901181106","article-title":"Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2017.03.018_bib0050","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejphar.2014.06.013","article-title":"Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-kappaBand MAPK pathways","volume":"740","author":"Jeong","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.molimm.2017.03.018_bib0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2012-201851","article-title":"Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups","volume":"72","author":"Kaufman","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.molimm.2017.03.018_bib0060","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M309251200","article-title":"Sequential autophosphorylation steps in the interleukin-1 receptor-associatedkinase-1 regulate its availability as an adapter in interleukin-1 signaling","volume":"279","author":"Kollewe","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.molimm.2017.03.018_bib0065","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1172\/JCI75821","article-title":"Inhibition of IRAK1\/4 sensitizes T cell acute lymphoblastic leukemia tochemotherapies","volume":"125","author":"Li","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.molimm.2017.03.018_bib0070","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.4049\/jimmunol.179.6.4125","article-title":"Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity","volume":"179","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2017.03.018_bib0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.molimm.2017.03.018_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2008.10.001","article-title":"The Pellino family: IRAK E3 ligases with emerging roles in innate immunesignalling","volume":"30","author":"Moynagh","year":"2009","journal-title":"Trends Immunol."},{"issue":"9894","key":"10.1016\/j.molimm.2017.03.018_bib0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(13)60889-2","article-title":"Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment","volume":"382","author":"Murphy","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.molimm.2017.03.018_bib0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/187153006779025685","article-title":"NF-kappaB and rheumatic diseases","volume":"6","author":"Okamoto","year":"2006","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.molimm.2017.03.018_bib0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fimmu.2016.00022","article-title":"Expression of TLR-7, MyD88 NF-kB, and INF-alpha in B lymphocytes of mayan women with systemic lupus erythematosus in Mexico","volume":"7","author":"Pacheco","year":"2016","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2017.03.018_bib0100","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","article-title":"MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis andcytokine production by targeting TRAF6 and IRAK1 proteins","volume":"290","author":"Park","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.molimm.2017.03.018_bib0105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/rheumatology\/kem298","article-title":"Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation","volume":"47","author":"Simmonds","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.molimm.2017.03.018_bib0110","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4049\/jimmunol.163.3.1682","article-title":"Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupuserythematosus is associated with decreased p65-RelA protein expression","volume":"163","author":"Wong","year":"1999","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2017.03.018_bib0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00011-013-0607-2","article-title":"Association of interleukin-1 receptor-associated kinase (IRAK1) genepolymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in aChinese Han population","volume":"62","author":"Zhai","year":"2013","journal-title":"Inflamm. Res."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017300895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017300895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T01:07:29Z","timestamp":1692752849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589017300895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":23,"alternative-id":["S0161589017300895"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.03.018","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}